文献速递慢病管理预防保健、筛查与疫苗

法国北部全科医生对IDF-DAR斋月禁食风险评分的认知调查

GPs' perceptions of the IDF-DAR risk score for fasting during Ramadan among patients with diabetes in Northern France.
PubMed 文献 · Br J Gen Pract · 2026-05-14

该研究在2025年3月至6月对法国上法兰西大区社区全科医生进行横断面在线问卷调查,共106人参与。结果显示仅6%了解IDF-DAR风险评分、2%实际使用,但89%认为该评分相关、95%认为可促进医患沟通,89%表示未来愿意使用,缺乏信息是主要障碍。

要点

  • 全科医生对IDF-DAR评分的知晓率仅6%,实际使用率仅2%。
  • 89%认为评分相关,95%认为能促进医患对话,89%愿意未来使用。
  • 感知相关性与易用性、清晰度及患者教育价值显著相关。

核心结论

  • IDF-DAR风险评分有助于结构化评估糖尿病患者斋月禁食风险,但需加强传播与培训以促进基层应用。

研究设计与样本

  • 2025年3月至6月在法国上法兰西大区对社区全科医生开展的横断面定量在线问卷调查,共106名全科医生参与,采用描述性与双变量分析。

主要发现

  • 仅6%的参与者了解IDF-DAR评分,仅2%实际使用该评分。
  • 89%的受访者认为该评分相关,95%认为可增强医患对话。
  • 感知相关性与易用性(p <0.001)、清晰度(p = 0.0035)及患者教育价值(p <0.001)显著相关。
  • 尽管知晓率低,89%表示未来愿意使用该评分,缺乏信息是主要障碍。

关键数值与推荐

  • 知晓IDF-DAR评分的全科医生占6%,使用该评分的占2%。
  • 认为评分相关的占89%,认为可增强医患对话的占95%,愿意未来使用的占89%。
  • 感知相关性与易用性关联的P值<0.001,与清晰度关联的P值为0.0035,与患者教育价值关联的P值<0.001。

临床怎么用

  • 在斋月前风险咨询中可考虑使用IDF-DAR评分结构化评估糖尿病患者的禁食风险。
  • 需通过传播评分信息与开展培训提升全科医生对该工具的知晓率与使用率。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fasting during Ramadan poses major challenges for patients with diabetes, who are at risk of glycaemic imbalance. To assist clinicians, the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) Alliance developed a risk score to guide fasting decisions. However, little is known about how this tool is perceived or used by French GPs. AIM: To explore GPs' perceptions of the relevance, acceptability, and barriers to the use of the IDF-DAR risk score in assessing fasting risk among patients with type 1 or type 2 diabetes. METHOD: A cross-sectional, quantitative online survey conducted among community-based GPs in the Hauts-de-France region between March and June 2025. The questionnaire assessed knowledge, perceived relevance, ease of use, and willingness to implement the score in clinical practice. Descriptive and bivariate analyses were performed. RESULTS: A total of 106 GPs participated. Knowledge of the IDF-DAR score was limited (6%), and its use was rare (2%). However, 89% of respondents considered it relevant, and 95% felt it could enhance doctor-patient dialogue. Perceived relevance was significantly associated with ease of use (p <0.001), clarity of it (p = 0.0035), and its educational value for patients (p <0.001). Despite low awareness, 89% expressed willingness to use it in the future; lack of information was the main barrier. CONCLUSION: The IDF-DAR risk score appears useful for structuring pre-Ramadan risk assessments in diabetes care, but greater dissemination and training are needed to support its adoption in primary care.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Baran J, Chaibi D, Kouidrat Y, et al. GPs' perceptions of the IDF-DAR risk score for fasting during Ramadan among patients with diabetes in Northern France. Br J Gen Pract. 2026. PMID: 42134931. doi:10.3399/bjgp26X745257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。